Retractable Technologies, Inc. (RVP) Stock Analysis & Investment Frameworks

Retractable Technologies, Inc. (RVP) stock analysis on Invetso. Review Retractable Technologies, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Retractable Technologies, Inc. Company Overview

Retractable Technologies, Inc. Key Financial Metrics

About Retractable Technologies, Inc.

Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.

Retractable Technologies, Inc. Investment Frameworks

Invetso analyzes Retractable Technologies, Inc. (RVP) across the following frameworks:

Explore More RVP Research